Wegovy is injected under the skin (subcutaneously) once a week, not into a vein or muscle. Wash or sanitise your hands, choose a clean,...

Wegovy has been tested in large clinical trials and shown to deliver sustained, clinically meaningful weight loss. Over-the-counter...

Yes, trial evidence shows that Wegovy works best when combined with healthy eating and physical activity, leading to average weight...

Many people on Wegovy report fewer food cravings and better control over eating, which can reduce stress around meals. Other drugs like...

Clinical trials included adults up to their mid-70s, and weight loss benefits were seen across age groups. There’s limited evidence...

Wegovy is made as a biologic medicine, meaning it uses recombinant technology to produce semaglutide, a protein-based drug. Mysimba and...

Both contain semaglutide and improve blood sugar by enhancing insulin release and reducing glucagon. Ozempic is specifically licensed for...

Yes — trials show Wegovy users lose more weight earlier than with Saxenda, thanks to its stronger appetite effect and weekly dosing. That...

In many cases, Wegovy can be used as the main weight loss medicine, especially when diet and exercise alone haven’t worked. However,...

Wegovy mimics the hormone GLP-1, acting on the brain to reduce appetite and slow digestion. Contrave (naltrexone/bupropion) affects brain...

Both Wegovy (semaglutide 2.4 mg) and Trulicity (dulaglutide) improve blood sugar, but semaglutide generally produces greater reductions...

Nausea? Hair loss? Headaches Acid reflux? Sulphur burps? These can be some of the most common side effects when using weight loss medications such as Mounjaro and Wegovy. We can help.

The most common side effects with Wegovy are gastrointestinal, such as nausea and diarrhoea, and these often lessen over time. Other...

Yes, Wegovy has strong evidence in people with type 2 diabetes, cardiovascular disease, and sleep apnoea, where weight loss can improve...

No, even though both contain semaglutide, they are licensed for different uses and come in different devices and doses. Doctors may...

The SELECT trial showed semaglutide 2.4 mg (Wegovy) reduced the risk of major heart problems in people with overweight or obesity and...

In the UK, coverage depends on NHS commissioning rather than insurance, and NICE now recommends Wegovy within specialist services....

Wegovy works directly on appetite signals in the brain, helping people feel full sooner and think less about food. Other medicines act...

Wegovy has shown sustained weight loss of around 15% at 68 weeks, and many participants maintained benefits at two years. Qsymia (not...

Survey and trial follow-ups suggest people report higher satisfaction with Wegovy than older GLP-1 drugs, mainly because of greater...